Literature DB >> 1860929

Determination of adriamycin in plasma and tissue biopsies.

S K Cox1, A V Wilke, D Frazier.   

Abstract

A simple, rapid and sensitive method for the extraction and high-performance liquid chromatographic analysis of adriamycin in tissue and plasma is described. Tissue (5-100 mg) and plasma (1 ml) samples underwent a C18 Sep-Pak extraction into methanol. Chromatography was performed on a muBondapakphenyl column using a mobile phase of acetonitrile-0.1 M ammonium formate (pH 4.0) with a flow-rate of 2 ml/min. Fluorometric detection was used with an excitation of 480 nm and an emission of 550 nm. The procedure produced a linear curve for the concentration range 25-1000 ng/ml. The development of the assay produced rapid, repeatable and accurate results for both small tissue samples and plasma.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1860929     DOI: 10.1016/0378-4347(91)80098-w

Source DB:  PubMed          Journal:  J Chromatogr


  4 in total

1.  Quantification of Doxorubicin and metabolites in rat plasma and small volume tissue samples by liquid chromatography/electrospray tandem mass spectroscopy.

Authors:  Robert D Arnold; Jeanine E Slack; Robert M Straubinger
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2004-09-05       Impact factor: 3.205

2.  Pharmacokinetics and antitumor effect of doxorubicin carried by stealth and remote loading proliposome.

Authors:  J P Wang; Y Maitani; K Takayama; T Nagai
Journal:  Pharm Res       Date:  2000-07       Impact factor: 4.200

3.  Time- and concentration-dependent penetration of doxorubicin in prostate tumors.

Authors:  J H Zheng; C T Chen; J L Au; M G Wientjes
Journal:  AAPS PharmSci       Date:  2001

4.  Modulation of doxorubicin concentration by cyclosporin A in brain and testicular barrier tissues expressing P-glycoprotein in rats.

Authors:  C S Hughes; S L Vaden; C A Manaugh; G S Price; L C Hudson
Journal:  J Neurooncol       Date:  1998-03       Impact factor: 4.130

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.